• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.13% Nasdaq Up0.14%

    Dicerna Pharmaceuticals, Inc. (DRNA)

    -NasdaqGS
    3.71 Down 0.15(3.89%) May 26, 4:00PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue 184   -   -  
    Cost of Revenue -   -   -  
    Gross Profit 184   -   -  
    Operating Expenses
    Research Development43,971  29,453  11,558  
    Selling General and Administrative19,240  15,648  5,820  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (63,027) (45,101) (17,378)
    Income from Continuing Operations
    Total Other Income/Expenses Net188  (2,639)(188)
    Earnings Before Interest And Taxes(62,839)(47,740)(17,566)
    Interest Expense -  199  952  
    Income Before Tax(62,839)(47,939)(18,518)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(62,839)(47,939)(18,518)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (62,839) (47,939) (18,518)
    Preferred Stock And Other Adjustments -  (204)(2,388)
    Net Income Applicable To Common Shares (62,839) (48,143) (20,906)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.